BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15254757)

  • 1. Targeting Ku protein for sensitizing of breast cancer cells to DNA-damage.
    Zhang L; Yoo S; Dritschilo A; Belyaev I; Soldatenkov V
    Int J Mol Med; 2004 Aug; 14(2):153-9. PubMed ID: 15254757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo.
    Maggiorella L; Deutsch E; Frascogna V; Chavaudra N; Jeanson L; Milliat F; Eschwege F; Bourhis J
    Cancer Res; 2003 May; 63(10):2513-7. PubMed ID: 12750274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nonhomologous end-joining pathway is required for protein phosphatase 2A promotion of DNA double-strand break repair.
    Wang Q; Gao F; Wang T; Flagg T; Deng X
    Neoplasia; 2009 Oct; 11(10):1012-21. PubMed ID: 19794960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation.
    Ayene IS; Ford LP; Koch CJ
    Mol Cancer Ther; 2005 Apr; 4(4):529-36. PubMed ID: 15827325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage.
    Schonn I; Hennesen J; Dartsch DC
    Apoptosis; 2011 Apr; 16(4):359-69. PubMed ID: 21107697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining.
    Douglas P; Gupta S; Morrice N; Meek K; Lees-Miller SP
    DNA Repair (Amst); 2005 Aug; 4(9):1006-18. PubMed ID: 15941674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of inositol phosphate-dependent mobility of Ku: depletion of the DNA-PK cofactor InsP6 inhibits Ku mobility.
    Byrum J; Jordan S; Safrany ST; Rodgers W
    Nucleic Acids Res; 2004; 32(9):2776-84. PubMed ID: 15150344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioresistance in a tumour cell line correlates with radiation inducible Ku 70/80 end-binding activity.
    Negroni A; Stronati L; Grollino MG; Barattini P; Gumiero D; Danesi DT
    Int J Radiat Biol; 2008 Apr; 84(4):265-76. PubMed ID: 18386192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of DNA double strand break repair and chromosome aberration formation.
    Iliakis G; Wang H; Perrault AR; Boecker W; Rosidi B; Windhofer F; Wu W; Guan J; Terzoudi G; Pantelias G
    Cytogenet Genome Res; 2004; 104(1-4):14-20. PubMed ID: 15162010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-homologous end-joining pathway is not involved in the radiosensitization of mammalian cells by heat shock.
    Dynlacht JR; Bittner ME; Bethel JA; Beck BD
    J Cell Physiol; 2003 Sep; 196(3):557-64. PubMed ID: 12891712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of double-strand breaks in DNA by human Rad52 protein.
    Van Dyck E; Stasiak AZ; Stasiak A; West SC
    Nature; 1999 Apr; 398(6729):728-31. PubMed ID: 10227297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated expression of Tob1 sensitizes breast cancer cells to ionizing radiation.
    Jiao Y; Ge CM; Meng QH; Cao JP; Tong J; Fan SJ
    Acta Pharmacol Sin; 2007 Oct; 28(10):1628-36. PubMed ID: 17883950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxia-telangiectasia-mutated-dependent activation of Ku in human fibroblasts exposed to hydrogen peroxide.
    Lee JH; Kim KH; Morio T; Kim H
    Ann N Y Acad Sci; 2006 Dec; 1091():76-82. PubMed ID: 17341604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ku autoantigen affects the susceptibility to anticancer drugs.
    Kim SH; Kim D; Han JS; Jeong CS; Chung BS; Kang CD; Li GC
    Cancer Res; 1999 Aug; 59(16):4012-7. PubMed ID: 10463600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of gross chromosomal rearrangements by yKu70-yKu80 heterodimer through DNA damage checkpoints.
    Banerjee S; Smith S; Myung K
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1816-21. PubMed ID: 16446442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Ku80 in microhomology-mediated end joining for DNA double-strand breaks in vivo.
    Katsura Y; Sasaki S; Sato M; Yamaoka K; Suzukawa K; Nagasawa T; Yokota J; Kohno T
    DNA Repair (Amst); 2007 May; 6(5):639-48. PubMed ID: 17236818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UHRF1 confers radioresistance to human breast cancer cells.
    Li X; Meng Q; Rosen EM; Fan S
    Int J Radiat Biol; 2011 Mar; 87(3):263-73. PubMed ID: 21067293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA binding activity of Ku during chemotherapeutic agent-induced early apoptosis.
    Iuchi K; Yagura T
    Exp Cell Res; 2016 Mar; 342(2):135-44. PubMed ID: 26976509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ku protein stimulates DNA end joining by mammalian DNA ligases: a direct role for Ku in repair of DNA double-strand breaks.
    Ramsden DA; Gellert M
    EMBO J; 1998 Jan; 17(2):609-14. PubMed ID: 9430651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.